Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

463.86 -5.82 (-1.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
69 70 Next >
News headline image
Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook ↗
The company's sales came in a hair light with losses wider than expected. 
Via Investor's Business Daily
News headline image
Vertex Reports Second Quarter 2024 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? ↗
Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market... 
Via Benzinga
News headline image
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know ↗
 
Via Benzinga
News headline image
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. 
Via Benzinga
Topics Economy
News headline image
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever ↗
These businesses are looking like increasingly attractive buys. 
Via The Motley Fool
News headline image
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November ↗
After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a... 
Via Benzinga
News headline image
The Top 3 Biotech Stocks to Buy Now Summer 2024 ↗
These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects. 
Via InvestorPlace
News headline image
Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock. ↗
Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing? 
Via Chartmill
News headline image
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
Check Out What Whales Are Doing With VRTX ↗
 
Via Benzinga
News headline image
Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame? ↗
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now. 
Via The Motley Fool
News headline image
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024 ↗
The investing guru likes to take the pulse of where the world will be tomorrow and these Cathie Wood stocks reflect that vision. 
Via InvestorPlace
News headline image
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now ↗
These companies are paving the way to future growth and market share in their respective industries. 
Via The Motley Fool
News headline image
Is Vertex Pharmaceuticals' Monopoly in Danger? ↗
As a shareholder, I am nowhere close to panic mode. 
Via The Motley Fool
News headline image
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗
Vertex shares have soared by triple-digit percentages over the past three years. 
Via The Motley Fool
News headline image
7 Biotech Stocks to Keep on Your Clinical Radar ↗
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. 
Via InvestorPlace
News headline image
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
3 Gene Editing Stocks Shaping the Future of Medicine ↗
Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions 
Via InvestorPlace
News headline image
2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street ↗
Neither of these predictive indicators has ever been wrong when back-tested for more than 150 years! 
Via The Motley Fool
News headline image
3 Monster Stocks in the Making to Buy Right Now ↗
They're small now, but these stocks could grow much larger. 
Via The Motley Fool
News headline image
The 3 Best Neuroscience Biotech Stocks to Buy Now ↗
Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now. 
Via InvestorPlace
News headline image
Looking for growth without the hefty price tag? Consider NASDAQ:VRTX. ↗
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) is not too expensive for the growth it is showing. 
Via Chartmill
News headline image
3 Gene Editing Stocks That Could Grow Your Wealth ↗
Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks. 
Via InvestorPlace
News headline image
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗
CRISPR Therapeutics could start reporting product revenue soon. 
Via The Motley Fool
News headline image
Bull Market and Beyond: 2 Stocks Just Waiting to Soar ↗
These innovative drugmakers are hard to ignore. 
Via The Motley Fool
News headline image
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split ↗
Revenue is climbing at these two drug companies -- and the trend should continue. 
Via The Motley Fool
News headline image
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever ↗
These companies have what it takes to stand the test of time in a portfolio. 
Via The Motley Fool
News headline image
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge. 
Via InvestorPlace
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.